Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
10,781,082
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
1,403,470
-
Shares change
-
+1,319,432
-
Total reported value, excl. options
-
$25,458,000
-
Value change
-
+$23,880,194
-
Number of buys
-
18
-
Number of sells
-
-5
-
Price
-
$18.14
Significant Holders of Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) as of Q1 2021
26 filings reported holding LTRN - Lantern Pharma Inc. - Common Stock, par value $0.0001 per share as of Q1 2021.
Lantern Pharma Inc. - Common Stock, par value $0.0001 per share (LTRN) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,403,470 shares
of 10,781,082 outstanding shares and own 13.02% of the company stock.
Largest 10 shareholders include Corriente Advisors, LLC (713,806 shares), VANGUARD GROUP INC (259,147 shares), FLAGSHIP HARBOR ADVISORS, LLC (147,671 shares), MORGAN STANLEY (50,702 shares), GEODE CAPITAL MANAGEMENT, LLC (45,830 shares), Redmond Asset Management, LLC (44,991 shares), MILLENNIUM MANAGEMENT LLC (42,106 shares), WOLFF WIESE MAGANA LLC (27,075 shares), BlackRock Inc. (23,650 shares), and NORTHERN TRUST CORP (12,629 shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.